vetameg- flunixin meglumine injection, solution
aspen veterinary resources, ltd - flunixin meglumine (unii: 8y3jk0jw3u) (flunixin - unii:356ib1o400), phenol (unii: 339ncg44tv) (phenol - unii:339ncg44tv) - indications horse : vetameg® (flunixin meglumine injection) is recommended for the alleviation of inflammation and pain associated with musculoskeletal disorders in the horse. it is also recommended for the alleviation of visceral pain associated with colic in the horse. cattle : vetameg® is indicated for the control of pyrexia associated with bovine respiratory disease, endotoxemia and acute bovine mastitis. vetameg® is also indicated for the control of inflammation in endotoxemia. contraindications horse : there are no known contraindications to this drug when used as directed. intra-arterial injection should be avoided. horses inadvertently injected intra-arterially can show adverse reactions. signs can be ataxia, incoordination, hyperventilation, hysteria, and muscle weakness. signs are transient and disappear without antidotal medication within a few minutes. do not use in horses showing hypersensitivity to flunixin meglumine. cattle : nsaids inhibit production of prostaglandins which
lidocaine injection
aspen veterinary resources, ltd. - lidocaine hydrochloride (unii: v13007z41a) (lidocaine - unii:98pi200987) - caution : federal law restricts this drug to use by or on the order of a licensed veterinarian. for animal use only keep out of reach of children indications lidocaine is a potent local anesthetic producing epidural, nerve conduction and infiltration anesthesia. lidocaine is contraindicated in animals with a known hypersensitivity to the drug.
meloxidyl- meloxicam suspension
aspen veterinary resources, ltd. - meloxicam (unii: vg2qf83cgl) (meloxicam - unii:vg2qf83cgl) - indications: meloxidyl oral suspension is indicated for the control of pain and inflammation associated with osteoarthritis in dogs. contraindications: dogs with known hypersensitivity to meloxicam should not receive meloxidyl oral suspension. do not use meloxidyl oral suspension in cats. acute renal failure and death have been associated with the use of meloxicam in cats.
aspirin bolus-240- aspirin tablet
aspen veterinary resources, ltd - aspirin (unii: r16co5y76e) (aspirin - unii:r16co5y76e) - for oral use only as an aid in reducing fever and in the relief of minor muscular aches and joint pains in cattle and horses. analgesic/antipyretic
aspirin powder- aspirin powder
aspen veterinary resources, ltd - aspirin (unii: r16co5y76e) (aspirin - unii:r16co5y76e) -
sulfadimethoxine concentrated solution 12.5% solution
aspen veterinary resources ltd - sulfadimethoxine (unii: 30cpc5ldex) (sulfadimethoxine - unii:30cpc5ldex) - broiler and replacement chickens: use for the treatment of disease outbreaks of coccidiosis, fowl cholera, and infectious coryza. meat producing turkeys: use for the treatment of disease outbreaks of coccidiosis and fowl cholera. dairy calves, dairy heifers and beef cattle: use for the treatment of shipping fever complex and bacterial pneumonia associated with pasteurella spp . sensitive to sulfadimethoxine, calf diphtheria and foot rot associated with fusobacterium necrophorum (sphaerophorus necrophorus) sensitive to sulfadimethoxine.
levafen- carprofen tablet, chewable
aspen veterinary resources®, ltd - carprofen (unii: ffl0d546ho) (carprofen - unii:ffl0d546ho) - levafen chewable tablets are indicated for the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs. levafen chewable tablets should not be used in dogs exhibiting previous hypersensitivity to carprofen.
delaquin- marbofloxacin tablet, chewable delaquin- marbofloxacin tablet, chewable
aspen veterinary resources®, ltd - marbofloxacin (unii: 8x09wu898t) (marbofloxacin - unii:8x09wu898t) - delaquintm chewable tablets are indicated for the treatment of infections in dogs and cats associated with bacteria susceptible to marbofloxacin. marbofloxacin and other quinolones have been shown to cause arthropathy in immature animals of most species tested, the dog being particularly sensitive to this side effect. marbofloxacin is contraindicated in immature dogs during the rapid growth phase (small and medium breeds up to 8 months of age, large breeds up to 12 months of age and giant breeds up to 18 months of age). marbofloxacin is contraindicated in cats under 12 months of age. marbofloxacin is contraindicated in dogs and cats known to be hypersensitive to quinolones.
coxiba- deracoxib tablet, chewable
aspen veterinary resources®, ltd - deracoxib (unii: vx29jb5xwv) (deracoxib - unii:vx29jb5xwv) - always provide “information for dog owners” sheet with prescription. carefully consider the potential benefits and risk of coxiba chewable tablets and other treatment options before deciding to use coxiba chewable tablets. use the lowest effective dose for the shortest duration consistent with individual response. osteoarthritis pain and inflammation: coxiba chewable tablets are indicated for the control of pain and inflammation associated with osteoarthritis in dogs. dosage and administration: osteoarthritis pain and inflammation: 0.45 – 0.91 mg/lb/day (1 to 2 mg/kg/day) as a single daily dose, as needed. dogs needing a dose of less than 12.5 mg can only be accurately dosed through use of the 12 mg tablet, which can be broken in half to provide 6 mg. do not attempt to accurately dose smaller dogs through the use of breaking larger tablets. inaccurate dosing may result in adverse drug events (see adverse reactions, animal safety, and post-approval experience). postoperative orthopedic pain and inflammation
ceritanttm- maropitant citrate tablet
aspen veterinary resources®, ltd. - maropitant citrate (unii: lxn6s3999x) (maropitant - unii:4xe2t9h4dh) - ceritant (maropitant citrate) tablets are indicated for the prevention of acute vomiting and the prevention of vomiting due to motion sickness in dogs.